• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [18947 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2015     Haute Autorite de sante (HAS) [Assessment of diagnostic and therapeutic parotid and submandibular sialendoscopy]
2009     Haute Autorite de sante (HAS) [Assessment of drug-eluting stents]
2007     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Assessment of effectiveness and cost-effectiveness of HPV testing in primary screening for cervical cancer]
2014     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Assessment of effectiveness and safety of Cyberknife and Gamma knife radiosurgery in intra and extracraneal lesions' treatment (update)]
2016     Basque Office for Health Technology Assessment (OSTEBA) [Assessment of factors related to the pharmaceutical expenditure in Primary Care, and prescription quality in chronic diseases]
2011     Haute Autorite de sante (HAS) [Assessment of glomerular filtration rate and serum creatinine levels in the diagnosis of chronic kidney disease in adults]
2010     Basque Office for Health Technology Assessment (OSTEBA) [Assessment of healthcare status and therapeutic recommendations concerning attention deficit hyperactivity disorder]
2010     Haute Autorite de sante (HAS) [Assessment of medical devices for home infusion]
2014     Haute Autorite de sante (HAS) [Assessment of non-invasive methods for measuring liver fibrosis in chronic hepatitis B. Initial assessment and follow-up of non-treated adult patients]
2011     The Netherlands Organisation for Health Research and Development (ZonMw) [Assessment of Perinatal Outcome after Sustained Tocolysis for Early Labour (APOSTEL II)]
2019     Haute Autorite de sante (HAS) [Assessment of pulp wound protection by direct pulp capping]
2014     Haute Autorite de sante (HAS) [Assessment of real-time optical endomicroscopy performed during mapping of Barrett's esophagus (BE) (for diagnosis of BE-associated early neoplasia)]
2014     Haute Autorite de sante (HAS) [Assessment of spinal cord stimulation]
2002     Finnish Office for Health Care Technology Assessment (Finohta) [Assessment of telemedicine in the Northern Ostrobothnia hospital district]
2011     National Evidence-based Healthcare Collaborating Agency (NECA) [Assessment of the effectiveness of sublingual immunotherapy and subcutaneous immunotherapy in allergic rhinitis and asthma]
2006     Basque Office for Health Technology Assessment (OSTEBA) [Assessment of the effectiveness of the intraoperative detection of the sentry ganglion in solid tumours]
2015     Haute Autorite de sante (HAS) [Assessment of the measurement of cytomegalovirus viral load by gene amplification in allograft recipients]
2013     Institut national d'excellence en sante et en services sociaux (INESSS) [Assessment of the PARLER (Programme d'Accès Rapide Lavallois en Rhumatologie) program]
2008     Basque Office for Health Technology Assessment (OSTEBA) [Assessment of the quality of the registration of administrative variables of the minimum basic data set of short-term hospitals of Osakidetza-Basque Health Service in 2005]
2006     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Assessment of the re-designed diagnosis process for colorectal cancer]
2009     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Assessment of the re-designed diagnosis process for colorectal cancer]
2014     Haute Autorite de sante (HAS) [Assessment of the risks associated with aesthetic mesotherapy practices]
2015     Haute Autorite de sante (HAS) [Assessment of the safety and conditions for conducting autologous fat grafting in reconstructive, restorative and cosmetic breast surgery]
2015     Institute for Clinical Effectiveness and Health Policy (IECS) [Assessment on nucleic acid amplification techniques (NAT) for human immunodeficiency, hepatitis C and hepatitis B virus screening in blood banks]
2010     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Assessment process of research projects submitted to the 2009 calling of the Fundacio La Marato de TV3. Rare diseases]
2011     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Assessment process of the research projects submitted to the 2010 call for topics of la Fundació La Marató de TV3. Acquired spinal cord and brain injuries]
2009     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Assessments tools for risk prediction of cardiovascular diseases]
2012     Basque Office for Health Technology Assessment (OSTEBA) [Assistance at normal childbirth. Guide for pregnant women, future parents, as well as their partners and relatives]
2015     Institut national d'excellence en sante et en services sociaux (INESSS) [Assisted reproduction]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Atazanavir/cobicistat (Evotaz®) in HIV infection]
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Atezolizumab in non-small cell lung cancer]
2017     Basque Office for Health Technology Assessment (OSTEBA) [ATOMs – Adjustable Transobturator Male System. Device for urinary incontinence]
2008     Committee for New Health Technology Assessment (CNHTA) [ATP7A gene, mutation analysis]
2008     Committee for New Health Technology Assessment (CNHTA) [ATP7A gene, mutation[sequencing]]
2009     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [AUDIT ONCOrisk: Quality of the information in the study about digestive oncological surgery results]
2000     Basque Office for Health Technology Assessment (OSTEBA) [Auditive implants: concept, indications and appropriate use]
2009     Committee for New Health Technology Assessment (CNHTA) [Auditory cortex stimulation]
2009     The Regional Health Technology Assessment Centre (HTA-centrum) [Auricular acupuncture for narcotic dependency]
2022     Basque Office for Health Technology Assessment (OSTEBA) [Autism spectrum disorder: scientific evidence on its detection, diagnosis and treatment]
2010     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Autism spectrum disorder: scientific knowledge about the detection, diagnosis and treatment]
2018     Haute Autorite de sante (HAS) [Autism spectrum disorder: Warning signs, detection, diagnosis and assessment in children and adolescents]
2009     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Autism treatment with orthomolecular therapy]
2010     Committee for New Health Technology Assessment (CNHTA) [Autofluorescence image(endoscopy)]
2007     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Autologous blood donations]
2009     Committee for New Health Technology Assessment (CNHTA) [Autologous blood injection]
2008     Committee for New Health Technology Assessment (CNHTA) [Autologous bone marrow cell infusion for advanced liver cirrhosis]
2008     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Autologous chondrocyte implantion. An updated systematic review and tutelage use extension]
2015     Norwegian Institute of Public Health (NIPH) [Autologous hematopoietic stemcell transplantation (HSCT) for multiple sclerosis]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Autologous lymph node transfer for lymphedema secondary to breast cancer]
2009     Committee for New Health Technology Assessment (CNHTA) [Autologous noncultured epidermal cellular transplantation]
2011     Committee for New Health Technology Assessment (CNHTA) [autologous platelet rich plasma application]
2010     Committee for New Health Technology Assessment (CNHTA) [Autologous platelet rich plasma application]
2021     Norwegian Institute of Public Health (NIPH) [Autologous stem cell transplantation for multiple sclerosis : rapid scoping review]
2013     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Automated reading methods of uterine cervical cytology]
2008     Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Avastin in ophthalmology]
2012     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Avastin® for age-related macular degeneration]
2010     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Azacitidine (Vidaza) for the treatment of myelodysplastic syndromes]
2011     Finnish Office for Health Care Technology Assessment (Finohta) [Azacitidine in the treatment of high-risk myelodysplastic syndrome]
2009     Committee for New Health Technology Assessment (CNHTA) [BAALC gene mRNA, quantitative [real-time RT-PCR]]
2015     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Balloon Eustachian tuboplasty for the treatment of Eustachian tube dysfunction - German short version and update of the correspondent EUnetHTA assessment]
2015     Andalusian Health Technology Assessment Area (AETSA) [Balloon eustachian tuboplasty for the treatment of eustachian tube dysfunction]
2009     Committee for New Health Technology Assessment (CNHTA) [Balloon tamponade for postpartum hemorrhage]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Bariatric surgery as treatment for obesity in subjects over 65 years old]
2010     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Bariatric surgery in diabetic type 2 patients with CMI at or above 30 kg/m2]
2016     Institute for Clinical Effectiveness and Health Policy (IECS) [Bariatric surgery to treat obesity with a body mass index (BMI) less than 40 kg/m2]
2008     The Regional Health Technology Assessment Centre (HTA-centrum) [Bariatric surgery]
2020     National Committee for Technology Incorporation (CONITEC) [Baricitinib (Olumiant) for patients with moderate to severe active rheumatoid arthritis]
2021     Institute for Clinical Effectiveness and Health Policy (IECS) [Baricitinib in COVID-19 patients]
2008     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Behaviour therapy for obesity treatment considering approved drug therapy]
2008     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Behaviour therapy for obesity treatment considering approved drug therapy]
2009     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Behavioural and skill-based early interventions in children with autism spectrum disorders]
2015     Institute for Clinical Effectiveness and Health Policy (IECS) [Belimumab for the treatment of Systemic Lupus Erythematosus]
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Bendamustine as first line therapy for indolent non-Hodgkin’s lymphoma]
2015     Institut national d'excellence en sante et en services sociaux (INESSS) [Bendamustine for the treatment of follicular lymphoma]
2011     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Benefit assessment of HPV testing in primary screening for cervical cancer]
2011     The Regional Health Technology Assessment Centre (HTA-centrum) [Benefit of phrenic nerve stimulation for patients with complete traumatic lesion of the spinal cord and loss of spontaneous breathing]
2007     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Benefits and risks of hormonal contraception for women]
2007     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Benefits and risks of hormonal contraception for women]
1997     Basque Office for Health Technology Assessment (OSTEBA) [Benign prostatic hyperplasia: diagnostic and treatment]
2011     The Swedish Council on Health Technology Assessment (SBU) [Benign Prostatic Obstruction (BPO)]
2007     Norwegian Knowledge Centre for the Health Services (NOKC) [Benzodiazepine treatment for drug-dependent subjects]
2018     Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale (CIUSSS) [Best practices to reduce medication administration errors (MAEs) in hospital centre (HC) and long term care facilities centre (LTCF)]
1999     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Beta-interferon treatment in RRMS and secondary progressive multiple sclerosis]
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Bevacizumab in age-related macular degeneration]
2012     Institute for Clinical Effectiveness and Health Policy (IECS) [Biabsorbable versus metalic screws for anterior cruciate ligament reconstruction]
2007     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Bilateral cochlear implants in children: effectiveness, safety and cost. Situation in the Spanish regions]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Bilateral cochlear implants in hearing loss]
2011     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Bioabsorbable everolimus-eluting coronary stent (BVS) for treatment of coronary artery disease]
2015     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Biodegradable stents for the treatment of refractory or recurrent benign oesophageal stenoses]
2013     Institute for Clinical Effectiveness and Health Policy (IECS) [Biofeedback for women with urinary, fecal or combined incontinence]
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Biofeedback in adults with fecal and/or urinary incontinence]
2011     Finnish Office for Health Care Technology Assessment (Finohta) [Bioimpedance in the estimation of dry weight in hemodialysis patients]
2011     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Bioimpedance vector analysis in the assessment of nutritional status and body fluid volume in patients with chronic renal failure]
2015     Institute for Clinical Effectiveness and Health Policy (IECS) [Biologic agents for the treatment of psoriasis]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Biological agents and tofacitinib in rheumatoid arthritis]
2013     Andalusian Health Technology Assessment Area (AETSA) [Biological therapies in the treatment of anaemia associated with chronic kidney disease: a comparison of efficacy and safety of different erythropoiesis-stimulating agents]
2013     Andalusian Health Technology Assessment Area (AETSA) [Biological therapies in the treatment of ankylosing spondylitis: a comparison of efficacy and safety between different biological inhibitors of tumour necrosis factor-alpha]
2011     Andalusian Health Technology Assessment Area (AETSA) [Biological therapies in the treatment of rheumatoid arthritis]
2012     Institute for Clinical Effectiveness and Health Policy (IECS) [Biological tissue adhesive versus standard suture in conjuctival autograft for the surgical treatment of pterygium]
2005     Unit of Health Economics and Technology Assessment in Health Care (HunHTA) [Biologicals in patients with psoriasis, infliximab (REMICADE) therapy]